Apex Biotechnology Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Apex Biotechnology has a total shareholder equity of NT$1.7B and total debt of NT$5.0M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are NT$2.3B and NT$549.4M respectively. Apex Biotechnology's EBIT is NT$109.2M making its interest coverage ratio -359.3. It has cash and short-term investments of NT$432.6M.
Wichtige Informationen
0.3%
Verhältnis von Schulden zu Eigenkapital
NT$5.00m
Verschuldung
| Zinsdeckungsgrad | -359.3x |
| Bargeld | NT$432.61m |
| Eigenkapital | NT$1.75b |
| Gesamtverbindlichkeiten | NT$549.42m |
| Gesamtvermögen | NT$2.29b |
Jüngste Berichte zur Finanzlage
Is Apex Biotechnology (TPE:1733) Using Too Much Debt?
Mar 30
These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely
Dec 16
Recent updates
Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around
Aug 06Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings
Mar 21Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business
Apr 17Is Apex Biotechnology (TPE:1733) Using Too Much Debt?
Mar 30Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?
Mar 10Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?
Feb 17A Look At Apex Biotechnology's (TPE:1733) Share Price Returns
Jan 27Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture
Jan 06These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely
Dec 16Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?
Nov 22Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 1733's short term assets (NT$1.5B) exceed its short term liabilities (NT$430.5M).
Langfristige Verbindlichkeiten: 1733's short term assets (NT$1.5B) exceed its long term liabilities (NT$118.9M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 1733 has more cash than its total debt.
Schulden abbauen: 1733's debt to equity ratio has reduced from 25.2% to 0.3% over the past 5 years.
Schuldendeckung: 1733's debt is well covered by operating cash flow (5299%).
Zinsdeckung: 1733 earns more interest than it pays, so coverage of interest payments is not a concern.